Skip to Content

1439 134 (Fenofibrate (Micronized) 134 mg)

Pill with imprint 1439 134 is Blue, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Torrent Pharmaceuticals Limited.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1439 134

Fenofibrate (micronized) 134 mg 1439 134

Fenofibrate (Micronized)

Imprint
1439 134
Strength
134 mg
Color
Blue
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Torrent Pharmaceuticals Limited
National Drug Code (NDC)
13668-0439
Inactive Ingredients
crospovidone, FD&C Blue No. 1, FD&C Red No. 40, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, gelatin, lactose monohydrate, magnesium stearate, polyethylene glycol 3350, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium stearyl fumarate, pregelatinized corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.